| Oncodesign Precision Medicine S.A.. (12/15/22). "Press Release: OPM and Servier Launch "FederAidd", an International Virtual Campus for Open Innovation to Accelerate and Make the Drug Discovery Process more Reliable Thanks to Artificial Intelligence". Pa |
2022-12-15 |
| NuPharm Group. (7/3/18). "Press Release: NuPharm Group Announces the Acquisition of Laboratoire Biodim in France". Paris. |
2018-07-03 |
| Novolyze. (1/17/18). "Press Release: Novolyze Raises €2.2 Million to Lower the Risk of Foodborne Illnesses". |
2018-01-17 |
| Novasep S.A.. (8/21/18). "Press Release: Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s". Lyon. |
2018-08-21 |
| Novasep S.A.. (6/11/18). "Press Release: Novasep Launches BioSC Pilot, Breakthrough Chromatography and DSP Skid for Biologics Purification". Lyon. |
2018-06-11 |
| Novasep S.A.. (4/25/18). "Press Release: Novasep Announces 2017 Financial Results. Sales Are up 4% at 282 M€, EBITDA Is up 4.3% at 29 M€". Lyon. |
2018-04-25 |
| Novasep S.A.. (3/7/17). "Press Release: Novasep Appoints Xavier de Saint Guilhem as Chief Financial Officer". Lyon. |
2017-03-07 |
| Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. |
2018-12-20 |
| Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel. |
2017-10-28 |
| Novartis AG. (10/25/17). "Press Release: Novartis Confirms Leadership in Multiple Sclerosis (MS) with Scientific Advancements and New Data presented at ECTRIMS". Basel. |
2017-10-25 |
| Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. |
2018-01-26 |
| Novalix SAS. (11/30/21). "Press Release: Novalix Signs Partnership Agreement to Design and Screen Sanofi’s New DNA-Encoded Libraries". Strasbourg. |
2021-11-30 |
| Novalix SAS. (1/25/21). "Press Release: Novalix Partners with Chemical.AI to Develop Artificial Intelligence Toolkit for Drug Discovery". Strasbourg & Wuhan. |
2021-01-25 |
| Novadiscovery. (11/22/18). "Press Release: Novadiscovery Welcomes Two New Members to Its Team to Strengthen Its Combined Expertise in Artificial Intelligence and Clinical Medicine". Lyon. |
2018-11-22 |
| Novadiscovery SAS. (1/9/20). "Press Release: Novadiscovery Raises Series A Financing to Scale Its in silico Clinical Trial Platform – Debiopharm Leads the Round with EUR 5 Million". |
2020-01-09 |
| Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. |
2018-09-26 |
| Novacyt S.A.. (7/3/23). "Press Release: Recommended Cash Offer. Novacyt UK Holdings Limited (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc [ RESTRICTED]". |
2023-07-03 |
| Novacyt S.A.. (7/29/21). "Press Release: David Allmond Announced as CEO Following Decision by Graham Mullis to Retire". Paris & Camberley. |
2021-07-29 |
| Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge. |
2017-07-20 |
| Novacyt S.A.. (6/20/17). "Press Release: Novacyt Successfully Completes €3.0M Fundraising". Paris & Cambridge. |
2017-06-20 |
| Novacyt S.A.. (4/6/17). "Press Release: Novacyt Announces Bond Issue". Paris & Cambridge. |
2017-04-06 |
| Novacyt S.A.. (4/27/17). "Press Release: Novacyt Full Year 2016 Results". Paris & Cambridge. |
2017-04-27 |
| Novacyt S.A.. (4/26/18). "Press Release: Novacyt Full Year 2017 Results". Paris & Camberley. |
2018-04-26 |
| Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge. |
2017-10-18 |
| Novacyt S.A.. (1/5/21). "Press Release: Executive Management and Proposed Board Changes". Paris & Camberley. |
2021-01-05 |
| Nosopharm SAS. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. |
2019-07-03 |
| Nosopharm SAS. (3/28/17). "Press Release: Nosopharm Raises €2.4 million ($2.6m) to Develop a novel Antibiotic Class". Lyon. |
2017-03-28 |
| Nosopharm SAS. (2/12/18). "Press Release: Nosopharm Receives €1 Million Loan from Bpifrance". Lyon. |
2018-02-12 |
| Nicox S.A.. (8/15/17). "Press Release: Nicox Announces €26.25 Million Financing [Not for distribution in or into the United States of America, Canada, Japan or Australia, except as permitted by applicable law]". Sophia Antipolis. |
2017-08-15 |
| Nicox S.A.. (3/9/17). "Press Release: Nicox Resubmits AC-170 (Zerivate) NDA to the U.S. FDA". Sophia Antipolis. |
2017-03-09 |
| Nicox S.A.. (3/1/17). "Press Release: Nicox to Participate at Two Upcoming Investor Conferences". Sophia Antipolis. |
2017-03-01 |
| Nicox S.A.. (2/9/17). "Press Release: Nicox to Present at the 6th Annual Leerink Partners Global Healthcare Conference". Sophia Antipolis. |
2017-02-09 |
| NFL Biosciences S.A.. (6/30/21). "Press Release: NFL Biosciences Raises €5.0M, Following Its Successful Initial Public Offering on Euronext Growth Partis [Not for United States of America, the United Kingdom, Canada, Australia or Japan]". Montpellier. |
2021-06-30 |
| Nextbiotix. (7/5/18). "Press Release: Nextbiotix Raises € 7m in a Series A Round to Tackle Inflammatory Bowel Diseases". Paris. |
2018-07-05 |
| Neovacs S.A.. (9/11/18). "Press Release: Neovacs Announces that Its Partner Biosense Global Has Exercised Its Option to Acquire the Exclusive Licence for IFNalpha Kinoid to Treat Lupus in China". Paris & Boston, MA. |
2018-09-11 |
| Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. |
2017-03-30 |
| Neovacs S.A.. (2/9/17). "Press Release: Neovacs Issued New Broad Patent in China for IFNalpha Kinoid". Paris. |
2017-02-09 |
| Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. |
2017-02-03 |
| Neovacs S.A.. (2/22/18). "Press Release: Neovacs Strengthens Its Intellectual Property in the USA". Paris & Boston, MA. |
2018-02-22 |
| Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris. |
2017-02-21 |
| Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. |
2017-01-05 |
| Neovacs S.A.. (1/25/17). "Press Release: Neovacs Reports First Positive Immunogenicity Results for IFN alpha Kinoid in Model of Type 1 Diabetes". Paris & Boston, MA. |
2017-01-25 |
| Nanobiotix S.A.. (7/26/18). "Press Release: Nanobiotix Signs a 40 M€ Non-dilutive Financing Agreement with the European Investment Bank". Paris & Cambridge, MA. |
2018-07-26 |
| Nanobiotix S.A.. (7/10/23). "Press Release: Nanobiotix Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3". Paris & Cambridge, MA. |
2023-07-10 |
| Nanobiotix S.A.. (6/21/18). "Press Release: Nanobiotix Announces Positive Phase II/III Topline Data in Soft Tissue Sarcoma with NBTXR3". Paris & Cambridge, MA. |
2018-06-21 |
| Nanobiotix S.A.. (5/28/19). "Press Release: Nanobiotix Announces the Launch of Curadigm. A New Nanotechnology Platform for Healthcare". Paris & Cambridge, MA. |
2019-05-28 |
| Nanobiotix S.A.. (4/6/17). "Press Release: Nanobiotix Successfully Completes approx. EUR 25.1 Million Private Placement of New Shares [Not for United States, Canada, Australia or Japan]". Paris & Cambridge, MA. |
2017-04-06 |
| Nanobiotix S.A.. (4/6/17). "Press Release: Nanobiotix Launches Capital Increase by Means of an Accelerated Bookbuild Offering [Not for United States, Canada, Australia or Japan]". Paris & Cambridge, MA. |
2017-04-06 |
| Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. |
2019-04-04 |
| Nanobiotix S.A.. (4/4/17). "Press Release: Nanobiotix Expands Its Clinical Development in Head and Neck Cancer and Immuno-oncology. New Clinical Data to Be Presented at ASCO". Paris & Cambridge, MA. |
2017-04-04 |
| Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. |
2019-04-02 |
| Nanobiotix S.A.. (3/30/18). "Press Release: Nanobiotix 2017 Annual Results". Paris & Cambridge, MA. |
2018-03-30 |
| Nanobiotix S.A.. (12/26/17). "Press Release: 2017 Review and 2018 Expected Milestones". Paris & Cambridge, MA. |
2017-12-26 |
| Nanobiotix S.A.. (1/16/19). "Press Release: Nanobiotix Plans to Conduct Registered Public Offering in the United States". Paris & Cambridge, MA. |
2019-01-16 |
| MYR GmbH. (6/10/20). "Press Release: MYR Pharmaceuticals Has Incorporated Its First European Subsidiary in France". Bad Homburg. |
2020-06-10 |
| Mutabilis S. A.. (10/17/17). "Press Release: Mutabilis Joins the European ENABLE Consortium to Fight Antibiotic Resistance". Paris. |
2017-10-17 |
| Mnemo Therapeutics (FR). (6/16/21). "Press Release: Mnemo Therapeutics Announces €75 Million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform". Paris. |
2021-06-16 |
| Microphyt. (7/11/19). "Press Release: Microphyt Raises €28.5 Million to Develop Its Portfolio of Microalgae-based Natural Solutions for Nutrition and Well-being". Baillargues. |
2019-07-11 |
| Microphyt S.A.. (7/30/18). "Press Release: Microphyt Is Strengthening Its Teams to Accelerate the Commercialization of Its Natural Active Ingredients Derived from Microalgae". |
2018-07-30 |
| Micropep Technologies SAS. (7/8/21). "Press Release: Micropep Raises EUR 8.5M (USD 10M) in Oversubscribed Series A Financing to Develop Innovative Small Peptide Solutions for Agriculture". Toulouse. |
2021-07-08 |
| Micropep Technologies SAS. (6/27/22). "Press Release: Micropep, Ag-Biotech innovator, Raises €8.75 Million from Global Syndicate to Bring Ground-breaking and Cost-effective Alternatives to Conventional Crop Protection Products to Market". Toulouse. |
2022-06-27 |
| Micropep Technologies SAS. (3/6/18). "Press Release: Micropep Technologies Completes a €4M Seed Round to Boost the Development of Its Unique Discovery Engine". Toulouse. |
2018-03-06 |
| Metafora Biosystems SAS. (6/11/18). "Press Release: Metafora Biosystems Receives €3.2 Million from European Commission’s H2020 SME Instrument Program". Paris. |
2018-06-11 |
| Mérieux Equity Partners SAS. (12/8/20). "Press Release: Cell-Easy Announces the Completion of a Financing Round to Accelerate Its Growth Trajectory in the Cell Therapy Sector, With Merieux Equity Partners as Lead Investor and Reference Shareholder". Toul |
2020-12-08 |
| Mérieux Equity Partners SAS. (1/8/20). "Press Release: Mérieux Equity Partners Successfully Completes the Fundraising of Mérieux Participations 3". Lyon. |
2020-01-08 |
| Meletios Therapeutics SAS. (8/30/21). "Press Release: Meletios Therapeutics Raises €3.8 Million for the Development of a New Generation of Antiviral Treatments". Paris. |
2021-08-30 |
| Meletios Therapeutics SAS. (2/28/22). "Press Release: Meletios Therapeutics Signs an Exclusive License Agreement with the Institut Pasteur for the Development of a New Class of Antivirals". Paris. |
2022-02-28 |
| Meiogenix SAS. (12/14/21). "Press Release: Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners". Paris. |
2021-12-14 |
| MedinCell S.A.. (6/16/20). "Press Release: MedinCell Announces the Great Success of Its Capital Increase and Raises 15.6 M€ [Not for publication nor to distribution in the United States, Canada, Japan or Australia]". Montpellier. |
2020-06-16 |
| MedinCell S.A.. (5/27/20). "Press Release: MedinCell Secures €10.9 Million Non-Dilutive Financing". Montpellier. |
2020-05-27 |
| MedinCell S.A.. (3/25/20). "Press Release: MedinCell Receives $ 6.4 Million Grant from Unitaid to Fight Malaria". Montpellier. |
2020-03-25 |
| MedinCell S.A.. (2/11/21). "Press Release: Tremendous Success for MedinCell’s €30 Million Capital Increase for Qualified Investors". Montpellier. |
2021-02-11 |
| MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier. |
2022-11-30 |
| MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. |
2019-11-28 |
| Medigene AG. (4/28/17). "Press Release: Medigene Announces Participation at Six International Conferences". Planegg. |
2017-04-28 |
| Medicen Paris Region. (9/7/17). "Press Release: BioWin and Medicen Focus on Developing Medical Imaging and Digital Health in Europe". Gosselies & Paris. |
2017-09-07 |
| Medicen Paris Region. (6/14/18). "Press Release: Medicen Paris Region Appoints Stéphane Roques as CEO". Paris. |
2018-06-14 |
| Medicen Paris Region. (5/23/17). "Press Release: French Tech Tour Healthcare Israel. Seven Start-ups Assess their Business Potential with Business France, Bpifrance and Medicen Paris Region". Paris. |
2017-05-23 |
| Medicen Paris Region. (4/20/20). "Press Release: Medicen Paris Region Appoints Jessica Leygues as CEO". Paris. |
2020-04-20 |
| Median Technologies S.A.. (12/14/23). "Press Release: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine". Sophia Antipolis & Saclay. |
2023-12-14 |
| MedDay Pharmaceuticals SAS. (3/10/20). "Press Release: MedDay Reports Top-line Data from Phase III Trial »SPI2« for Treatment of Progressive Forms of Multiple Sclerosis". Paris. |
2020-03-10 |
| McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. |
2017-01-09 |
| McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. |
2017-01-06 |
| Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. |
2018-10-24 |
| Mablink Bioscience SAS. (4/27/21). "Press Release: Mablink Bioscience, the Next Generation ADC Company, Raises €4 Million from a Syndicate of Private Investors". Lyon. |
2021-04-27 |
| Mablink Bioscience SAS. (10/21/21). "Press Release: Mablink Bioscience and Emergence Therapeutics Enter into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy". Lyon & Duisburg. |
2021-10-21 |
| Mablink Bioscience SAS. (10/18/23). "Press Release: Mablink Bioscience Enters an Agreement to be Acquired by Lilly". Lyon. |
2023-10-18 |
| Mablink Bioscience SAS. (10/14/22). "Press Release: Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners". Lyon. |
2022-10-14 |
| MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. |
2023-06-21 |
| MaaT Pharma. (5/28/20). "Press Release: MaaT Pharma Appoints Savita Bernal as Chief Business Officer". Lyon. |
2020-05-28 |
| MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon. |
2020-02-05 |
| MaaT Pharma. (12/1/20). "Press Release: MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)". Lyon. |
2020-12-01 |
| MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon. |
2021-10-15 |
| L’Oréal S.A.. (12/5/18). "Press Release: L'Oréal Creates a Corporate Venture Capital Fund Dedicated to Accompanying Innovative Startups". Clichy. |
2018-12-05 |
| Lysogene S.A.. (7/1/20). "Press Release: Lysogene Announces a Research Collaboration with the Weizmann Institute of Science". Paris. |
2020-07-01 |
| Lysogene S.A.. (4/21/17). "Press Release: 2016 Annual Results". Paris & Cambridge, MA. |
2017-04-21 |
| Lysogene S.A.. (4/20/17). "Press Release: Lysogene Announces Selection of MRI Interventions’ SmartFlow Cannula for Phase II/III Clinical Study in MPS IIIA". Paris & Cambridge, MA. |
2017-04-20 |
| Lysogene S.A.. (3/12/20). "Press Release: Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta [Not for US, CA, AU or JP]". Paris. |
2020-03-12 |
| Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. |
2017-02-07 |
| Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-02-21 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 
Source
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
